Stemtech (STEK) Cash & Equivalents (2012 - 2025)

Stemtech has disclosed Cash & Equivalents across 14 years of filings, most recently posting $238245.0 for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $238245.0, down 6.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $238245.0 (down 6.68% YoY), and the FY2025 annual result was $238245.0, down 6.68% from the prior year.
• Cash & Equivalents came in at $238245.0 for Q4 2025 at Stemtech, down from $255416.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.6 million in Q3 2021 to a low of $114166.0 in Q4 2023.
• The 5-year median for Cash & Equivalents is $273224.5 (2024), against an average of $376566.7.
• Across the five-year window, Cash & Equivalents plunged 92.3% in 2022 and surged 162.93% in 2023, its largest moves.
• Stemtech's Cash & Equivalents stood at $828206.0 in 2021, then slumped by 84.0% to $132487.0 in 2022, then decreased by 13.83% to $114166.0 in 2023, then jumped by 123.62% to $255298.0 in 2024, then slipped by 6.68% to $238245.0 in 2025.
• The last three Cash & Equivalents figures came in at $238245.0 (Q4 2025), $255416.0 (Q3 2025), and $272450.0 (Q2 2025), per Business Quant data.